Caucasian, 22% Japanese, and other ethnicity (of 300 or more participants) included Hispanic/Latin 67 American (0.2%), Chinese (0.2%), Middle Eastern (0.3%), African/black (0.5%), and Other (1.0%).
Introduction
InterLACE invited all individual studies to provide relevant data including a list of variables, survey questionnaires, data dictionaries/formats, and protocols or standard operating procedures. were also available at multiple surveys in the longitudinal studies.
189
3. Chronic disease outcomes: data on CVD (stroke and heart diseases including general heart 190 disease, heart attack, heart failure and angina) and diabetes ( Morocco (Figure 1) . Twelve studies provided longitudinal data with at least two waves of surveys
246
and five years of follow-up, while eight studies provided only cross-sectional baseline data ( obese, while the corresponding figure for Japanese studies (JMWHS and JNHS) was less than 2%.
270
Regarding reproductive factors, 40-60% of women reported that they had their first period (menarche) 
282
The prevalence of CVD and diabetes at baseline for cross-sectional studies and at the end of the 283 follow-up period for the 12 longitudinal studies are provided in Table 3 . Overall, the median age at 284 last follow-up for disease outcome was 56 years (IQR: 48-64 years). The prevalence of CVD and 285 diabetes were higher in longitudinal studies that followed participants into their 60s or 70s of age.
286
The overall prevalence of CVD was 7.2%, but it ranged from 0.9-24.6% between studies with the 287 lowest in JNHS (median age 41 years) and the highest in ELSA (median age 65 years). Of the total 288 CVD cases, 2.0% were stroke and 5.8% were heart disease. There was little variation in the prevalence
289
of stroke between studies, except for ELSA, which had more than double the prevalence (5.6%) of 290 other studies. A wider variation was evident in the prevalence of heart disease across studies, which 291 ranged from 0.6-22.4%. The overall prevalence of diabetes was 5.1%, with JNHS having the lowest
292
(1.3%) prevalence and SWAN the highest (13.2%).
294

Discussion
295
With the pooled information from 230,000 mid-aged women across 20 cohort and cross-sectional 296 studies, from ten countries, InterLACE has sufficient scale and heterogeneity to study the health of 
